目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook

3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Pharmaceuticals in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Pharmaceuticals in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Pharmaceuticals in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Pharmaceuticals in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Pharmaceuticals in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis

14 Macroeconomic Indicators
14.1. Country data

15 Pharmaceuticals in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis

16 Macroeconomic Indicators
16.1. Country data

17 Pharmaceuticals in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis

18 Macroeconomic Indicators
18.1. Country data

19 Company Profiles
19.1. Johnson & Johnson
19.2. Apotex, Inc.
19.3. Laboratoires Pierre Fabre SA
19.4. F. Hoffmann-La Roche Ltd
19.5. Boehringer Ingelheim GmbH
19.6. A Menarini Industrie Farmaceutiche Riunite Srl
19.7. Chiesi Farmaceutici SpA
19.8. Recordati S.p.A.
19.9. Daiichi Sankyo Co Ltd
19.10. Astellas Pharma Inc.
19.11. Takeda Pharmaceutical Company Limited
19.12. Mitsubishi Tanabe Pharma Corporation
19.13. Sanofi SA
19.14. Bayer AG
19.15. Les Laboratoires Servier
19.16. Novartis AG
19.17. GSK plc.
19.18. Pfizer Inc.
19.19. Merck & Co., Inc.
19.20. AstraZeneca PLC

20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2017-26
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2017-21
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2021-26
Table 4: Canada pharmaceuticals market value: $ billion, 2016-21
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2021
Table 6: Canada pharmaceuticals market share: % share, by value, 2021
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Table 8: Canada size of population (million), 2017-21
Table 9: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 10: Canada gdp (current prices, $ billion), 2017-21
Table 11: Canada inflation, 2017-21
Table 12: Canada consumer price index (absolute), 2017-21
Table 13: Canada exchange rate, 2017-21
Table 14: France pharmaceuticals market value: $ billion, 2016-21
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2021
Table 16: France pharmaceuticals market share: % share, by value, 2021
Table 17: France pharmaceuticals market value forecast: $ billion, 2021-26
Table 18: France size of population (million), 2017-21
Table 19: France gdp (constant 2005 prices, $ billion), 2017-21
Table 20: France gdp (current prices, $ billion), 2017-21
Table 21: France inflation, 2017-21
Table 22: France consumer price index (absolute), 2017-21
Table 23: France exchange rate, 2017-21
Table 24: Germany pharmaceuticals market value: $ billion, 2016-21
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2021
Table 26: Germany pharmaceuticals market share: % share, by value, 2021
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Table 28: Germany size of population (million), 2017-21
Table 29: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 30: Germany gdp (current prices, $ billion), 2017-21
Table 31: Germany inflation, 2017-21
Table 32: Germany consumer price index (absolute), 2017-21
Table 33: Germany exchange rate, 2017-21
Table 34: Italy pharmaceuticals market value: $ billion, 2016-21
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2021
Table 36: Italy pharmaceuticals market share: % share, by value, 2021
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2021-26
Table 38: Italy size of population (million), 2017-21
Table 39: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 40: Italy gdp (current prices, $ billion), 2017-21
Table 41: Italy inflation, 2017-21
Table 42: Italy consumer price index (absolute), 2017-21
Table 43: Italy exchange rate, 2017-21
Table 44: Japan pharmaceuticals market value: $ billion, 2016-21
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2021
Table 46: Japan pharmaceuticals market share: % share, by value, 2021
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2021-26
Table 48: Japan size of population (million), 2017-21
Table 49: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 50: Japan gdp (current prices, $ billion), 2017-21
Table 51: Japan inflation, 2017-21
Table 52: Japan consumer price index (absolute), 2017-21
Table 53: Japan exchange rate, 2017-21
Table 54: Russia pharmaceuticals market value: $ billion, 2016-21
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2021
Table 56: Russia pharmaceuticals market share: % share, by value, 2021
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Table 58: Russia size of population (million), 2017-21
Table 59: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 60: Russia gdp (current prices, $ billion), 2017-21
Table 61: Russia inflation, 2017-21
Table 62: Russia consumer price index (absolute), 2017-21
Table 63: Russia exchange rate, 2017-21
Table 64: United Kingdom pharmaceuticals market value: $ billion, 2016-21
Table 65: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2021
Table 66: United Kingdom pharmaceuticals market share: % share, by value, 2021
Table 67: United Kingdom pharmaceuticals market value forecast: $ billion, 2021-26
Table 68: United Kingdom size of population (million), 2017-21
Table 69: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 70: United Kingdom gdp (current prices, $ billion), 2017-21
Table 71: United Kingdom inflation, 2017-21
Table 72: United Kingdom consumer price index (absolute), 2017-21
Table 73: United Kingdom exchange rate, 2017-21
Table 74: United States pharmaceuticals market value: $ billion, 2016-21
Table 75: United States pharmaceuticals market geography segmentation: $ billion, 2021
Table 76: United States pharmaceuticals market share: % share, by value, 2021
Table 77: United States pharmaceuticals market value forecast: $ billion, 2021-26
Table 78: United States size of population (million), 2017-21
Table 79: United States gdp (constant 2005 prices, $ billion), 2017-21
Table 80: United States gdp (current prices, $ billion), 2017-21
Table 81: United States inflation, 2017-21
Table 82: United States consumer price index (absolute), 2017-21
Table 83: United States exchange rate, 2017-21
Table 84: Johnson & Johnson: key facts
Table 85: Johnson & Johnson: Annual Financial Ratios
Table 86: Johnson & Johnson: Key Employees
Table 87: Johnson & Johnson: Key Employees Continued
Table 88: Apotex, Inc.: key facts
Table 89: Apotex, Inc.: Key Employees
Table 90: Laboratoires Pierre Fabre SA: key facts

List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2017-26
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2021
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2017-21
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2021-26
Figure 5: Canada pharmaceuticals market value: $ billion, 2016-21
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 7: Canada pharmaceuticals market share: % share, by value, 2021
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2021
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2021
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2021
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2021
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2021
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2021
Figure 15: France pharmaceuticals market value: $ billion, 2016-21
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 17: France pharmaceuticals market share: % share, by value, 2021
Figure 18: France pharmaceuticals market value forecast: $ billion, 2021-26
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2021
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2021
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2021
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2021
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2021
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2021
Figure 25: Germany pharmaceuticals market value: $ billion, 2016-21
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 27: Germany pharmaceuticals market share: % share, by value, 2021
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2021
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2021
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2021
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2021
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2021
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2021
Figure 35: Italy pharmaceuticals market value: $ billion, 2016-21
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 37: Italy pharmaceuticals market share: % share, by value, 2021
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2021-26
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2021
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2021
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2021
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2021
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2021
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2021
Figure 45: Japan pharmaceuticals market value: $ billion, 2016-21
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 47: Japan pharmaceuticals market share: % share, by value, 2021
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2021-26
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2021
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2021
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2021
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2021
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2021
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2021
Figure 55: Russia pharmaceuticals market value: $ billion, 2016-21
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 57: Russia pharmaceuticals market share: % share, by value, 2021
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Figure 59: Forces driving competition in the pharmaceuticals market in Russia, 2021
Figure 60: Drivers of buyer power in the pharmaceuticals market in Russia, 2021
Figure 61: Drivers of supplier power in the pharmaceuticals market in Russia, 2021
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2021
Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2021
Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2021
Figure 65: United Kingdom pharmaceuticals market value: $ billion, 2016-21
Figure 66: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 67: United Kingdom pharmaceuticals market share: % share, by value, 2021
Figure 68: United Kingdom pharmaceuticals market value forecast: $ billion, 2021-26
Figure 69: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2021
Figure 70: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2021
Figure 71: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2021
Figure 72: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2021
Figure 73: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2021
Figure 74: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2021
Figure 75: United States pharmaceuticals market value: $ billion, 2016-21
Figure 76: United States pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 77: United States pharmaceuticals market share: % share, by value, 2021
Figure 78: United States pharmaceuticals market value forecast: $ billion, 2021-26
Figure 79: Forces driving competition in the pharmaceuticals market in the United States, 2021
Figure 80: Drivers of buyer power in the pharmaceuticals market in the United States, 2021
Figure 81: Drivers of supplier power in the pharmaceuticals market in the United States, 2021
Figure 82: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2021
Figure 83: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2021
Figure 84: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2021